November 9, 2011 12:50 pm by Frank Vinluan | 1 Comments
A week after GlaxoSmithKline (NYSE:GSK) reached a $3 billion federal settlement over claims it illegally marketed Avandia and other drugs, the drugmaker now faces pressure to resolve the thousands of ...
Read more
February 3, 2011 4:40 pm by Frank Vinluan | 0 Comments
GlaxoSmithKline took a loss in the fourth quarter of 2010 but the company's stock still managed to climb in trading Thursday. The company announced a stock buyback program that pleases ...
Read more
January 31, 2011 12:38 pm by Frank Vinluan | 1 Comments
GlaxoSmithKline has settled its first case involving former diabetes blockbuster Avandia, but it will most certainly not be the last word on the matter. ...
Read more
January 17, 2011 2:04 pm by Frank Vinluan | 0 Comments
GlaxoSmithKline's Avandia problems are resulting in the company setting aside $3.4 billion to pay for legal costs related to its former diabetes drug, which has been linked to greater cardiovascular ...
Read more
October 22, 2010 8:47 am by Mary Vanac | 0 Comments
Defunding by Congress and implementation by governors are the two major threats facing healthcare reform, Tom Daschle, former U.S. Senate majority leader who almost became Department of Health and Human ...
Read more
September 30, 2010 8:53 am by Mary Vanac | 0 Comments
McDonald's Corp. has warned federal regulators that it could drop its health insurance plan for nearly 30,000 hourly restaurant workers unless regulators waive a new requirement of the U.S. ...
Read more
September 24, 2010 8:56 am by Mary Vanac | 0 Comments
What does Cleveland Clinic cardiologist (and Avandia whistleblower) Steven Nissen have to say about Thursday's Food and Drug Administration decision to allow diabetes drug Avandia to stay on the market ...
Read more
September 23, 2010 8:43 am by Mary Vanac | 0 Comments
Swiss drugmaker Novartis just got Food and Drug Administration approval to sell the first pill that can slow the progression of multiple sclerosis. Gilenya will go head-to-head with injectable medicines, ...
Read more
September 6, 2010 1:37 pm by Mary Vanac | 0 Comments
The British Medical Journal today raised more questions about whether diabetes drug Avandia should ever have been approved for patients in the United States and Europe, and whether the ...
Read more
August 25, 2010 9:17 am by Mary Vanac | 0 Comments
The two researchers whose claims of injury led a federal judge to ban research using human embryonic stem cells late Monday have a history of disputes with colleagues as well ...
Read more
Highlights of the important and the interesting from the world of healthcare:Massachusetts nurses strike on tap? After a near-miss of a lengthy nurses strike in Minnesota, some nurses in Massachusetts ...
Read more
Highlights of the important and the interesting from the world of healthcare:Troubled nurses skip from state to state. Nurse Craig Peske was fired from a hospital in Wausau, Wisconsin, in ...
Read more
Highlights of the important and the interesting from the world of healthcare:Is venture capital just a three-state game? It was in the second quarter, according to data from the always-insightful ...
Read more
Could Avandia be the drug industry’s ReGen?The New York Times reported Tuesday that for over a decade, GlaxoSmithKline hid the results of its own study that showed its diabetes drug ...
Read more
Highlights of the important and the interesting from the world of healthcare:iPhone videochat a “game-changing tool” for doctors: Two doctors participated in what may be the first documented medical consultation ...
Read more
